B-Cell CLL/lymphoma 6, Member B (BCL6B) (Middle Region) Peptide
-
- Target See all BCL6B products
- BCL6B (B-Cell CLL/lymphoma 6, Member B (BCL6B))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BCL6B antibody (Catalog #: ARP40045_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BCL6B (B-Cell CLL/lymphoma 6, Member B (BCL6B))
- Synonyms
- BAZF Peptide, ZBTB28 Peptide, ZNF62 Peptide, Bazf Peptide, RGD1563179 Peptide, B-cell CLL/lymphoma 6B Peptide, B cell CLL/lymphoma 6, member B Peptide, B-cell CLL/lymphoma 6, member B Peptide, BCL6B Peptide, Bcl6b Peptide, bcl6b Peptide
- Background
-
BCL6B acts as a sequence-specific transcriptional repressor in association with BCL6. BCL6B may function in a narrow stage or be related to some events in the early B-cell development.
Alias Symbols: BAZF, ZBTB28, ZNF62
Protein Interaction Partner: BCL6
Protein Size: 480 - Molecular Weight
- 52 kDa
- Gene ID
- 255877
- NCBI Accession
- NM_181844, NP_862827
- UniProt
- Q8N143
-